Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen

There are no effective treatment options for most patients with metastatic colorectal cancer (mCRC). mCRC remains a leading cause of tumor-related death, with a five-year survival rate of only 15%, highlighting the urgent need for novel pharmacological products. Current standard drugs are based on c...

Descripción completa

Detalles Bibliográficos
Autores principales: Plüss, Louis, Peissert, Frederik, Elsayed, Abdullah, Rotta, Giulia, Römer, Jonas, Dakhel Plaza, Sheila, Villa, Alessandra, Puca, Emanuele, De Luca, Roberto, Oxenius, Annette, Neri, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228411/
https://www.ncbi.nlm.nih.gov/pubmed/37243574
http://dx.doi.org/10.1080/19420862.2023.2217964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228411/
https://www.ncbi.nlm.nih.gov/pubmed/37243574
http://dx.doi.org/10.1080/19420862.2023.2217964

Ejemplares similares